Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Enable the production of CellProtect in Sweden for confirmatory clinical trials.
| Reference number | 2018-04367 |
| Coordinator | CellProtect Nordic Pharmaceuticals AB |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | October 2018 - December 2019 |
| Status | Completed |
| Venture | Competence centre |
Last updated 28 January 2020
Reference number 2018-04367
